Why is Bliss GVS Pharma falling/rising?

As of 11-Sep, Bliss GVS Pharma Ltd's stock price is currently at 154.30, reflecting an increase of 1.2, or 0.78%. The stock has shown a trend reversal, gaining after five consecutive days of decline. Despite this recent uptick, the stock has underperformed in the short term, with a 1-week return of -1.47% and a 1-month return of -10.96%. The stock's performance today has outpaced its sector by 0.31%, although there has been a decline in investor participation, with delivery volume falling by 2.07% against the 5-day average. The company maintains a low debt-to-equity ratio and has a fair valuation, but its profits have decreased by 3.6% over the past year, despite a notable 22.61% return during that same period.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has gained 1.03% over the past week and 1.17% over the past month. While Bliss GVS Pharma has outperformed the BSE500 over the long term, including a 22.61% return in the last year, its recent short-term struggles highlight a divergence from the broader market trends. The stock's liquidity remains adequate for trading, but the declining delivery volume suggests cautious sentiment among investors. Overall, the stock's recent rise may be attributed to a technical rebound after a period of decline, yet the underlying fundamentals indicate mixed signals regarding its future performance.